PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19845543-4	2010	Prostaglandin E(2) (PGE(2)) and tumor necrosis factor alpha (TNF-alpha) levels were increased 96 h post-UVB in acutely irradiated animals and both mediators were modified by topical naproxen application-PGE(2) was decreased while TNF-alpha was increased.	Naproxen	182-190	tumor necrosis factor	Mus musculus	32-59	
19845543-4	2010	Prostaglandin E(2) (PGE(2)) and tumor necrosis factor alpha (TNF-alpha) levels were increased 96 h post-UVB in acutely irradiated animals and both mediators were modified by topical naproxen application-PGE(2) was decreased while TNF-alpha was increased.	Naproxen	182-190	tumor necrosis factor	Mus musculus	61-70	
19845543-4	2010	Prostaglandin E(2) (PGE(2)) and tumor necrosis factor alpha (TNF-alpha) levels were increased 96 h post-UVB in acutely irradiated animals and both mediators were modified by topical naproxen application-PGE(2) was decreased while TNF-alpha was increased.	Naproxen	182-190	tumor necrosis factor	Mus musculus	230-239	
19845543-8	2010	Furthermore, reduction in the incidence of tumor lesions by naproxen may be due to its ability to increase TNF-alpha levels as well as to decrease PGE(2).	Naproxen	60-68	tumor necrosis factor	Mus musculus	107-116	
8013267-4	1993	The results corroborated the stimulation of TNF alpha production by NSAIDs (indomethacin, naproxen, ibuprofen) and indicated that the stimulation rank-ordered with the potency of inhibition of PGHS-1.	Naproxen	90-98	tumor necrosis factor	Mus musculus	44-53	
18710815-6	2008	Naproxen treatment notably reduces PGE2 production and iNOS expression, reflecting the COX-NOS crosstalk already reported, although it causes an important increment in TNF-alpha synthesis in the epidermis of irradiated mice.	Naproxen	0-8	tumor necrosis factor	Mus musculus	168-177	
25681154-11	2015	In naproxen-induced gastric damage, FOR0810 prevented gastric injury, decreased gastric MPO activity and leukocyte adherence, associated with a decrease in TNFalpha and IL-1beta gastric concentrations.	Naproxen	3-11	tumor necrosis factor	Mus musculus	156-164